Profusa, Inc. Common Stock PFSA · Stock Open Profusa, Inc. Common Stock in new tab
Profusa, Inc. Common Stock Analysis (PFSA)
Is Profusa, Inc. Common Stock a good investment? Profusa, Inc. Common Stock (PFSA) is currently trading at 1.30 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that Profusa, Inc. Common Stock is undervalued compared to historical market norms.
Investor FAQ
Does Profusa, Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Profusa, Inc. Common Stock?
Profusa, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
| Split Date | Split Ratio to 1 |
|---|---|
| Feb. 9, 2026 | 1:100 |
| July 7, 2026 | 1:25 |
| Aug. 17, 2026 | 1:4 |
Community Discussion